A phase-II study with idarubicin, etoposide and prednisone (IVPP), in patients with refractory or early relapsed intermediate or high grade non-Hodgkin's lymphoma
| dc.contributor.author | Xiros, N. | en |
| dc.contributor.author | Economopoulos, T. | en |
| dc.contributor.author | Fountzilas, G. | en |
| dc.contributor.author | Pavlidis, N. | en |
| dc.contributor.author | Samantas, E. | en |
| dc.contributor.author | Raptis, S. | en |
| dc.date.accessioned | 2015-11-24T19:39:56Z | |
| dc.date.available | 2015-11-24T19:39:56Z | |
| dc.identifier.issn | 0390-6078 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/24280 | |
| dc.rights | Default Licence | - |
| dc.subject | Adult | en |
| dc.subject | Aged | en |
| dc.subject | Antineoplastic Combined Chemotherapy Protocols/*therapeutic use | en |
| dc.subject | Etoposide/administration & dosage | en |
| dc.subject | Female | en |
| dc.subject | Humans | en |
| dc.subject | Idarubicin/administration & dosage | en |
| dc.subject | Lymphoma, Non-Hodgkin/*drug therapy | en |
| dc.subject | Male | en |
| dc.subject | Middle Aged | en |
| dc.subject | Prednisolone/administration & dosage | en |
| dc.subject | Recurrence | en |
| dc.title | A phase-II study with idarubicin, etoposide and prednisone (IVPP), in patients with refractory or early relapsed intermediate or high grade non-Hodgkin's lymphoma | en |
| heal.access | campus | - |
| heal.fullTextAvailability | TRUE | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/10091424 | - |
| heal.journalName | Haematologica | en |
| heal.journalType | peer-reviewed | - |
| heal.language | en | - |
| heal.publicationDate | 1999 | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.type | journalArticle | - |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.type.en | Journal article | en |